Human myoblasts were transplanted in nude mice. The efficacy of these transplantations was analyzed using a monoclonal antibody (NCLDys3) specific for human dystrophin. This antibody did not reveal any dystrophin in nude mice that did not receive a human myoblast transplantation. However, about 30 days after a human myoblast transplantation, dystrophin-positive muscle fibers were observed. They were not abundant, and were present either in small clusters or isolated. This technique follows the fate of myoblast transplantation in animals that already have dystrophin, and distinguishes between new dystrophin-positive fibers due to the transplantation and the revertant fibers in mdx mice. Moreover, this technique does not require any labelling of the myoblasts before transplantation. It can also be used to detect dystrophin produced following the fusion of myoblasts transfected with the human dystrophin gene.
AlameddineH.S.DehaupasM.FardeauM.Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro.An experimental model for testing cultured cell myogenicity. Muscle Nerve12: 544-555; 1989.
2.
ArahataK.IshiuraS.IshiguroT.TsukaharaT.SuharaY.EguchiC.IshiharaT.NonakaI.OzawaE.SugitaH.Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.Nature333: 861-863; 1988.
3.
BeamK.G.Duchenne muscular dystrophy: Localizing the gene product.Nature333: 798-799; 1988.
4.
BlauH.M.HughesS.M.Retroviral lineage markers for assessing myoblast fate in vivo.Adv. Exp. Med. Biol.280: 201-204; 1990.
5.
BonillaE.SamittC.E.MirandaA.F.HaysA.P.SalviatiG.DimauroS.KunkelL.M.HoffmanE.P.RowlandL.P.Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.Cell54: 447-452; 1988.
6.
ChenM.LiH.J.FangQ.GoodwinT.G.FlorendoJ.A.LawP.K.Dystrophin cytochemistry in mdx mouse muscles injected with labelled normal myoblasts.Cell Transplantation1: 17-22; 1992.
7.
CossuG.ZaniB.ColettaM.BoucheM.PacifictM.MolinaroM.In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles.A comparison with embryonic myogenic cells. Cell Differ.9: 357-368; 1980.
8.
GussoniE.PavlathG.K.LanctotA.M.SharmaK.MillerR.G.SteinmanL.BlauA.M.Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.Nature356: 435-438; 1992.
9.
HamR.G.St-ClairJ.A.WebsterC.BlauH.M.Improved media for normal human muscle satellite cells: Serum free clonal growth and enhanced growth with no serum.In Vitro Cell Dev. Biol.24(8): 833-844; 1988.
10.
HoffmanE.P.KnudsonC.M.CampbellR.P.KunkelL.M.Subcellular fractionation of dystrophin to the trials of skeletal muscle.Nature330: 754-758; 1987.
11.
HoffmanE.P.MorganJ.E.WatkinsS.C.SlayterH.S.PartridgeT.A.Somatic suppression/reversion of the mouse mdx phenotype in vivo.J. Neurol. Sci.99: 9-25; 1990.
12.
HoffmanE.P.HudeckiM.S.RosenbergP.A.PollinaC.M.KunkelL.M.Cell and fiber-type distribution of dystrophin.Neuron1: 411-420; 1988.
HuardJ.LabrecqueC.DansereauG.RobitailleL.TremblayJ.P.Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts.Muscle and Nerve14: 178-182; 1991.
15.
KarpatiG.Approaches to the introduction of normal alleles into skeletal muscle fibers for therapeutic purposes in Duchenne muscular dystrophy. In: KakulasB.A.McHowellJ.RosesA.D., eds. Duchenne muscular dystrophy (animal models and genetic manipulations).New York: Raven Press Ltd.;1992: 223-236.
16.
KarpatiG.PouliotY.Zubrzycka-GaarnE.CarpenterS.RayP.N.WortonR.G.HollandP.Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.Am. J. Pathol.135: 2732; 1989.
17.
KarpatiG.Non dystrophic myoblast transplantation into dystrophic muscle.Muscle Nerve12: 337-339; 1989.
18.
LabrecqueC.HuardJ.DansereauG.AlbertN.TremblayJ.P.In vitro bromodeoxyuridine labelling of nuclei: application to myotubes hybridization.J. Histochem. Cytochem.39(10): 1421-1426; 1991.
19.
LabrecqueC.HuardJ.DansereauG.RobitailleL.TremblayJ.P.A new technique to identify hybrid myotubes in vitro without culture fixation.J. Histochem. Cytochem.39(1): 139-143; 1991.
20.
LawP.K.GoodwinT.G.FangQ.DuggiralaV.LarkinC.FlorendoJ.A.KirbyD.S.DeeringM.B.LiH.J.ChenM.YooT.J.CornettJ.LiL.M.ShirzadA.QuinleyT.HolcombR.L.Feasibility, safety and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.Cell Transplantation1: 235-244; 1992.
21.
LawP.K.GoodwinT.G.LiH.J.Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice.Transplantation Proc.20: 1114-1119; 1988.
22.
LawP.K.GoodwinT.G.WangN.G.Normal myoblast injection provide genetic treatment for murine dystrophy.Muscle Nerve11: 525-533; 1988.
23.
MenkeA.JockushH.Decreased osmotic stability of dystrophin less muscle cells from the mdx mouse.Nature349: 69-71; 1991.
24.
MirandaA.F.BonillaE.MastucciG.MoraesC.T.HaysA.P.DimauroS.Immunocytochemical study of dystrophin in muscle from patients with Duchenne muscular dystrophy and unaffected control patients.Am. J. Pathol.132: 410-416; 1988.
25.
MorganJ.E.Practical aspects of myoblasts implantation: investigations of two inherited myopathies in animals. In: EastwoodA.KarpatiG.GriggsR., eds. Myoblast transfer therapy.New York: 1990: Plenum; 89-96.
26.
MorganJ.E.WattD.J.SloperJ.C.PartridgeJ.A.Partial correction of an inherited defect of skeletal muscle by grafts of normal muscle precursor cells.J. Neurol. Sci.86: 137-147; 1988.
27.
MorganJ.E.HoffmanE.P.PartridgeT.A.Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse.J. Cell Biol.111: 2437-2449; 1990.
28.
NicholsonL.V.B.JohnsonM.A.Gardner-MedwinD.BhattachayaS.HarrisJ.B.Heterogenecity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.Acta Neuropathol.80: 239-250; 1990.
29.
PartridgeT.A.Invited review: Myoblast transfer, a possible therapy for inherited myopathies.Muscle Nerve14: 197-212; 1991.
30.
PartridgeT.A.MorganJ.E.CoultonG.R.HoffmanE.P.KunkelL.M.Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts.Nature337: 176-179; 1989.
31.
PartridgeT.GrandsM.StopperJ.C.Evidence of fusion between host and donor myoblasts in skeletal muscle grafts.Nature275: 306-308; 1978.
32.
SalviatiG.BettoR.GeoldoS.BiasiaE.BonillaE.MirandaA.F.DimauroS.Cell fractionation studies indicate that dystrophin is a protein of surface membrane of skeletal muscle.Biochem. J.258: 837-841; 1989.
33.
SatohA.LabrecqueC.TremblayJ.P.Utilization of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.J. Histochem. Cytochem. (in press).
34.
SugitaH.ArahataK.IshiguroT.SuharaY.TsukaharaT.IshiuraJ.EguchiC.NonakaI.OzawaE.Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA.Proc. Jpn. Acad.64: 37-39; 1988.
35.
WatkinsS.C.HoffmanE.P.SlayterH.S.KunkelL.M.Immunoelectron miscroscopic localization of dystrophin in myofibres.Nature333: 863-866; 1988.
36.
YasinR.Van BeersG.NurseK.C.E.AlaniS.LondonD.N.ThompsonE.J.A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells.J. Neurol. Sci.32: 347-360; 1977.
37.
Zubrzycka-GaarnE.E.BulmanD.E.KarpatiG.BurghesA.H.M.BelfallB.KlamutH.J.TalbotJ.HodgesR.S.RayP.N.WortonR.G.The Duchenne muscular dystrophy gene is localized in the sarcolemma of human skeletal muscle.Nature333: 466-469; 1988.
